Strides Pharma acquires USFDA approved manufacturing facility in the US

SPI has acquired the manufacturing facility under an asset purchase agreement with Micelle Biopharma, Inc. for a consideration of US$0.5mn and will invest up to US$10mn to build incremental capabilities and add additional dosage formats.

from India Infoline News Service https://ift.tt/33VowbT